InsiderSignalSign in
← Insider buys

KITE

Kite Pharma, Inc.

No insider bought or sold Kite Pharma, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo
Follow KITE

KITE over the last year

Prices for KITE aren't in yet.

KITE after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

85 insider filings since 2016, newest first

KITESell

Cynthia M Butitta · COO

$760K−3.0%Sep 27
KITESell

Shawn Tomasello · Chief Commercial Officer

$755K−6.0%Sep 27
KITESell

Helen Susan Kim · EVP, Business Development

$570K−13.0%Sep 27
KITESell

Timothy L. Moore · EVP, Technical Operations

$1.4M−20.0%Sep 27
KITESell

Jeffrey Wiezorek · SVP Clinical Development

$949K−17.0%Sep 27
KITESell

David D Chang · EVP, R, D, Chief Medical Offic

$1.4M−12.0%Sep 27
KITESell

Paul L Jenkinson · CFO

$170K−7.0%Sep 27
KITESell

Arie Belldegrun · Chair, President and CEO

$4.7M−1.0%Sep 27
KITESell

Cynthia M Butitta · COO

$1.8M−11.0%Aug 14
KITESell

Helen Susan Kim · EVP, Business Development

$751K−25.0%Aug 14
KITESell

Helen Susan Kim · EVP, Business Development

$9.6M−81.0%Aug 10
KITESell

Timothy L. Moore · EVP, Technical Operations

$660K−11.0%Aug 4
KITESell

Timothy L. Moore · EVP, Technical Operations

$1.3M−20.0%Aug 3
KITESell

Helen Susan Kim · EVP, Business Development

$2.9M−59.0%Aug 1
KITESell

Cynthia M Butitta · COO

$1.5M−11.0%Jul 11
KITESell

Jeffrey Wiezorek · SVP Clinical Development

$1.0M−32.0%Jul 6
KITESell

Cynthia M Butitta · COO

$504K−4.0%Jun 27
KITESell

Owen N. Witte · Director

$2.5M−25.0%Jun 26
KITESell

Steven B Ruchefsky · Director

$1.8M−9.0%Jun 16
KITESell

Farah Champsi · Director

$1.8M−24.0%Jun 16
KITESell

Cynthia M Butitta · COO

$885K−8.0%Jun 12
KITESell

Roy Doumani · Director

$1.3M−8.0%Jun 9
KITESell

Helen Susan Kim · EVP, Business Development

$174K−11.0%Jun 5
KITEBuy

Ran Nussbaum · Director

$679K−187.0%May 11
KITEBuy

Paul L Jenkinson · CFO

$250K+49.0%May 10
KITEBuy

Steven B Ruchefsky · Director

$97K+1.0%May 10
KITEBuy

Arie Belldegrun · Chair, President and CEO

$1.2M+1.0%May 9
KITEBuy

David Bonderman · Director

$3.4M+2.0%May 9
KITESell

Helen Susan Kim · EVP, Business Development

$197K−11.0%May 3
KITESell

David D Chang · EVP, R, D, Chief Medical Offic

$1.6M−29.0%May 3
KITESell

Farah Champsi · Director

$1.6M−19.0%May 1
KITESell

Cynthia M Butitta · COO

$1.2M−11.0%Apr 27
KITESell

Farah Champsi · Director

$10.2M−55.0%Apr 26
KITESell

Farah Champsi · Director

$9.5M−34.0%Apr 17
KITESell

Cynthia M Butitta · COO

$410K−4.0%Apr 4
KITESell

David D Chang · EVP, R, D, Chief Medical Offic

$1.6M−29.0%Apr 4
KITESell

Helen Susan Kim · EVP, Business Development

$196K−11.0%Apr 4
KITESell

Cynthia M Butitta · COO

$777K−8.0%Mar 28
KITESell

Cynthia M Butitta · COO

$1.7M−15.0%Mar 10
KITESell

Jeffrey Wiezorek · SVP Clinical Development

$1.4M−46.0%Mar 2
KITESell

David D Chang · EVP, R, D, Chief Medical Offic

$4.7M−54.0%Mar 2
KITESell

Roy Doumani · Director

$1.4M−16.0%Mar 2
KITESell

Helen Susan Kim · EVP, Business Development

$3.4M−73.0%Mar 2
KITESell

Cynthia M Butitta · COO

$2.9M−25.0%Mar 1
KITESell

Jeffrey Wiezorek · SVP Clinical Development

$77K−7.0%Feb 6
KITESell

Cynthia M Butitta · COO

$506K−8.0%Feb 1
KITESell

Cynthia M Butitta · COO

$501K−8.0%Jan 10
KITESell

Jeffrey Wiezorek · SVP Clinical Development

$75K−7.0%Jan 10
KITESell

Cynthia M Butitta · COO

$126K−3.0%Dec 22
KITESell

Jeffrey Wiezorek · SVP Clinical Development

$36K−5.0%Dec 22
Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.